News in brief: Sleep studies key to PA screening; Expanded listing for semaglutide; Diabetes research receives a boost

Call to step up screening for primary aldosteronism People with both hypertension and obstructive sleep apnoea (OSA) should be routinely screened for primary aldosteronism (PA). A prospective study of 85 patients referred for sleep studies found the proportion of the total cohort with likely PA was 2.4% and possible PA was 11.8%. However among the ...

Already a member?

Login to keep reading.

© 2021 the limbic